Detalles de la búsqueda
1.
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study.
Lancet Oncol
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710187
2.
Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors.
Cancer Sci
; 115(3): 894-904, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38178783
3.
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
J Natl Compr Canc Netw
; : 1-9, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744306
4.
Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1.
Int J Clin Oncol
; 29(1): 1-19, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38019341
5.
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 29(6): 647-680, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38609732
6.
Phase I study of the irreversible fibroblast growth factor receptor 1-4 inhibitor futibatinib in Japanese patients with advanced solid tumors.
Cancer Sci
; 114(2): 574-585, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35838190
7.
First-in-human study of E7130 (a tumor microenvironment-ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose-escalation part.
Cancer
; 129(15): 2348-2359, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080942
8.
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Breast Cancer Res Treat
; 202(3): 473-483, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37688665
9.
Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study).
BMC Cancer
; 23(1): 1098, 2023 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951905
10.
Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours.
Gastric Cancer
; 26(3): 339-351, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913072
11.
Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study.
Jpn J Clin Oncol
; 53(2): 105-114, 2023 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36373891
12.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors.
Int J Clin Oncol
; 28(8): 941-955, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300720
13.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition.
Int J Clin Oncol
; 28(10): 1237-1258, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599324
14.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors.
Int J Clin Oncol
; 28(7): 827-840, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212982
15.
A phase 1 trial of xentuzumab, an IGF-neutralizing antibody, in Japanese patients with advanced solid tumors.
Cancer Sci
; 113(3): 1010-1017, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34870878
16.
Chronological improvement in precision oncology implementation in Japan.
Cancer Sci
; 113(11): 3995-4000, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35976133
17.
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.
Cancer Sci
; 113(11): 3646-3656, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35876224
18.
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.
BMC Med
; 20(1): 105, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296300
19.
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients.
Acta Med Okayama
; 76(6): 661-671, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36549768
20.
[NTRK Gene Fusions and Treatment in NTRK Fusion-Positive Solid Cancers].
Gan To Kagaku Ryoho
; 49(10): 1048-1050, 2022 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-36281593